Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-048304
Filing Date
2024-12-02
Accepted
2024-12-02 16:55:23
Documents
14

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 105443
2 ex1_001.jpg GRAPHIC 9677
3 ex2_001.jpg GRAPHIC 1615626
4 ex2_002.jpg GRAPHIC 4194582
5 ex2_003.jpg GRAPHIC 2242082
6 ex2_004.jpg GRAPHIC 3052394
7 ex2_005.jpg GRAPHIC 2497055
8 ex2_006.jpg GRAPHIC 2885000
9 ex2_007.jpg GRAPHIC 2827795
10 ex2_008.jpg GRAPHIC 2497932
11 ex2_009.jpg GRAPHIC 1855698
12 ex2_010.jpg GRAPHIC 1389980
13 ex3_001.jpg GRAPHIC 502129
14 ex3_002.jpg GRAPHIC 395091
  Complete submission text file 0001493152-24-048304.txt   35782687
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241519845
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)